The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease

It is a truism of modern biomedical science that the development of therapies expected to slow or arrest the progression of a disease requires as detailed an understanding of its molecular and cellular pathogenesis as possible. In turn, the cloning of novel gene products implicated in a disease ofte...

Full description

Saved in:
Bibliographic Details
Published inTrends in Cell Biology Vol. 8; no. 11; pp. 447 - 453
Main Author Selkoe, Dennis J
Format Book Review Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:It is a truism of modern biomedical science that the development of therapies expected to slow or arrest the progression of a disease requires as detailed an understanding of its molecular and cellular pathogenesis as possible. In turn, the cloning of novel gene products implicated in a disease often leads to new insights about fundamental features of protein structure and function. A particularly compelling example of this beneficial interplay between basic and applied cell biology arises from the exciting recent progress in deciphering Alzheimer's disease (AD). This review discusses the current understanding of the cell biology of two proteins crucial for the pathogenesis of AD, the β-amyloid precursor protein and presenilin.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Feature-3
ObjectType-Review-1
ISSN:0962-8924
1879-3088
DOI:10.1016/S0962-8924(98)01363-4